Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Monson

Showing results (71-80 of 178) with videos related to

Pageof 18
Sort By:
European Journal of Endocrinology|October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonistW M Drake, C Parkinson, S A Akker, et al.
Clinical Endocrinology|November 18, 2003
The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacementF M Swords, P V Carroll, J Kisalu, et al.
Clinical Endocrinology|January 13, 2001
Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titrationP J Jenkins, S Akker, S L Chew, et al.
Clinical Endocrinology|January 13, 2001
Concurrent secretion of aldosterone and cortisol from an adrenal adenoma - value of MRI in diagnosisC A Allan, G Kaltsas, L Perry, et al.
European Journal of Endocrinology|March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomantW M Drake, R A Loureiro, C Parkinson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 1998
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisoloneW M Drake, J P Monson, P J Trainer, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumorsG A Kaltsas, J J Mukherjee, P N Plowman, et al.
Journal of the Royal Society of Medicine|July 1, 1990
Impact of conventional and three-dimensional thallium-technetium scans on surgery for primary hyperparathyroidismB J Jenkins, M S Newell, A W Goode, et al.
The Quarterly Journal of Medicine|December 1, 1993
Does the rapid response to cisplatin-based chemotherapy justify its use as primary treatment for intracranial germ-cell tumours?S Vijayaraghavan, C Brock, J P Monson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Predicting relapse after transsphenoidal surgery for Cushing's diseaseG C Toms, M I McCarthy, M J Niven, et al.
Pageof 18

Showing results (71-80 of 178) with videos related to

Sort By:
Pageof 18
European Journal of Endocrinology|October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonistW M Drake, C Parkinson, S A Akker, et al.
Clinical Endocrinology|November 18, 2003
The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacementF M Swords, P V Carroll, J Kisalu, et al.
Clinical Endocrinology|January 13, 2001
Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titrationP J Jenkins, S Akker, S L Chew, et al.
Clinical Endocrinology|January 13, 2001
Concurrent secretion of aldosterone and cortisol from an adrenal adenoma - value of MRI in diagnosisC A Allan, G Kaltsas, L Perry, et al.
European Journal of Endocrinology|March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomantW M Drake, R A Loureiro, C Parkinson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 1998
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisoloneW M Drake, J P Monson, P J Trainer, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumorsG A Kaltsas, J J Mukherjee, P N Plowman, et al.
Journal of the Royal Society of Medicine|July 1, 1990
Impact of conventional and three-dimensional thallium-technetium scans on surgery for primary hyperparathyroidismB J Jenkins, M S Newell, A W Goode, et al.
The Quarterly Journal of Medicine|December 1, 1993
Does the rapid response to cisplatin-based chemotherapy justify its use as primary treatment for intracranial germ-cell tumours?S Vijayaraghavan, C Brock, J P Monson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Predicting relapse after transsphenoidal surgery for Cushing's diseaseG C Toms, M I McCarthy, M J Niven, et al.
Pageof 18